Evaluation of [ − 2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta
![Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis](https://www.degruyter.com/document/doi/10.1515/cclm-2012-0410/asset/graphic/j_cclm-2012-0410_fig_003.jpg)
Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis
![NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 5S (2018) NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 5S (2018)](https://jnccn.org/view/journals/jnccn/16/5S/0620fig01.jpeg)
NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 5S (2018)
![Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature – topic of research paper in Clinical medicine. Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature – topic of research paper in Clinical medicine.](https://cyberleninka.org/viewer_images/859140/f/1.png)
Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature – topic of research paper in Clinical medicine.
![2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases 2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpcan.2013.50/MediaObjects/41391_2014_Article_BFpcan201350_Fig2_HTML.jpg)
2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases
![−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text −2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-016-0131-0/MediaObjects/12894_2016_131_Fig2_HTML.gif)
−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text
![PD06-06 IMPORTANCE OF [-2] PROPSA MEASUREMENT IN A DIAGNOSIS OF PROSTATE CANCER: PROSTATE HEALTH INDEX TRIAL (PROPHET) - DIAGNOSTIC IMPACTS OF CLINICAL LABORATORY-BASED INDICES ON GLEASON GRADE GROUP ≥2 OR ≥3 CANCER PD06-06 IMPORTANCE OF [-2] PROPSA MEASUREMENT IN A DIAGNOSIS OF PROSTATE CANCER: PROSTATE HEALTH INDEX TRIAL (PROPHET) - DIAGNOSTIC IMPACTS OF CLINICAL LABORATORY-BASED INDICES ON GLEASON GRADE GROUP ≥2 OR ≥3 CANCER](https://www.auajournals.org/cms/asset/b95043ee-6e2e-4c0c-baf3-9f994247d77e/fx1.jpg)
PD06-06 IMPORTANCE OF [-2] PROPSA MEASUREMENT IN A DIAGNOSIS OF PROSTATE CANCER: PROSTATE HEALTH INDEX TRIAL (PROPHET) - DIAGNOSTIC IMPACTS OF CLINICAL LABORATORY-BASED INDICES ON GLEASON GRADE GROUP ≥2 OR ≥3 CANCER
![2proPSA and Prostate Health Index Usefulness for the Diagnosis of Prostate Cancer for PSA Range between 3 and 10 ng/ml 2proPSA and Prostate Health Index Usefulness for the Diagnosis of Prostate Cancer for PSA Range between 3 and 10 ng/ml](https://clinmedjournals.org/articles/iauc/iauc-4-041-002.gif)
2proPSA and Prostate Health Index Usefulness for the Diagnosis of Prostate Cancer for PSA Range between 3 and 10 ng/ml
![−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report – topic of research paper in Clinical medicine. Download −2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report – topic of research paper in Clinical medicine. Download](https://cyberleninka.org/viewer_images/926818/f/1.png)
−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report – topic of research paper in Clinical medicine. Download
![2]proPSA e Prostate Health Index (phi): che cosa sono? quando sono utili? - Dr. Francesco Varvello, urologo e andrologo 2]proPSA e Prostate Health Index (phi): che cosa sono? quando sono utili? - Dr. Francesco Varvello, urologo e andrologo](https://image.jimcdn.com/app/cms/image/transf/none/path/s21d176b569682d9d/image/icb5469c22bc7d9a6/version/1605475842/image.png)
2]proPSA e Prostate Health Index (phi): che cosa sono? quando sono utili? - Dr. Francesco Varvello, urologo e andrologo
![PSA synthesis and PSA isoforms. PSA synthesis begins with the cleavage... | Download Scientific Diagram PSA synthesis and PSA isoforms. PSA synthesis begins with the cleavage... | Download Scientific Diagram](https://www.researchgate.net/profile/Shingo-Hatakeyama/publication/309031559/figure/fig1/AS:416385223151616@1476285381306/PSA-synthesis-and-PSA-isoforms-PSA-synthesis-begins-with-the-cleavage-of-the-proenzyme_Q640.jpg)